Featured Research

from universities, journals, and other organizations

Medical marijuana laws reduce traffic deaths, preliminary research suggests

Date:
November 30, 2011
Source:
University of Colorado Denver
Summary:
A new study shows that laws legalizing medical marijuana lead to fewer traffic deaths and less consumption of alcohol.

A groundbreaking new study shows that laws legalizing medical marijuana have resulted in a nearly nine percent drop in traffic deaths and a five percent reduction in beer sales.

"Our research suggests that the legalization of medical marijuana reduces traffic fatalities through reducing alcohol consumption by young adults," said Daniel Rees, professor of economics at the University of Colorado Denver who co-authored the study with D. Mark Anderson, assistant professor of economics at Montana State University.

The researchers collected data from a variety of sources including the National Survey on Drug Use and Health, the Behavioral Risk Factor Surveillance System, and the Fatality Analysis Reporting System.

The study is the first to examine the relationship between the legalization of medical marijuana and traffic deaths.

"We were astounded by how little is known about the effects of legalizing medical marijuana," Rees said. "We looked into traffic fatalities because there is good data, and the data allow us to test whether alcohol was a factor."

Anderson noted that traffic deaths are significant from a policy standpoint.

"Traffic fatalities are an important outcome from a policy perspective because they represent the leading cause of death among Americans ages five to 34," he said.

The economists analyzed traffic fatalities nationwide, including the 13 states that legalized medical marijuana between 1990 and 2009. In those states, they found evidence that alcohol consumption by 20- through 29-year-olds went down, resulting in fewer deaths on the road.

The economists noted that simulator studies conducted by previous researchers suggest that drivers under the influence of alcohol tend to underestimate how badly their skills are impaired.They drive faster and take more risks.In contrast, these studies show that drivers under the influence of marijuana tend to avoid risks.

However, Rees and Anderson cautioned that legalization of medical marijuana may result in fewer traffic deaths because it's typically used in private, while alcohol is often consumed at bars and restaurants.

"I think this is a very timely study given all the medical marijuana laws being passed or under consideration," Anderson said. "These policies have not been research-based thus far and our research shows some of the social effects of these laws. Our results suggest a direct link between marijuana and alcohol consumption."

The study also examined marijuana use in three states that legalized medical marijuana in the mid-2000s, Montana, Rhode Island, and Vermont.Marijuana use by adults increased after legalization in Montana and Rhode Island, but not in Vermont.There was no evidence that marijuana use by minors increased.

Opponents of medical marijuana believe that legalization leads to increased use of marijuana by minors.

According to Rees and Anderson, the majority of registered medical marijuana patients in Arizona and Colorado are male.In Arizona, 75 percent of registered patients are male; in Colorado, 68 percent are male.Many are under the age of 40.For instance, 48 percent of registered patients in Montana are under 40.

"Although we make no policy recommendations, it certainly appears as though medical marijuana laws are making our highways safer," Rees said.


Story Source:

The above story is based on materials provided by University of Colorado Denver. Note: Materials may be edited for content and length.


Journal Reference:

  1. D. Mark Anderson, Daniel I. Rees. Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption. IZA Discussion Paper, November 2011 [link]

Cite This Page:

University of Colorado Denver. "Medical marijuana laws reduce traffic deaths, preliminary research suggests." ScienceDaily. ScienceDaily, 30 November 2011. <www.sciencedaily.com/releases/2011/11/111129123257.htm>.
University of Colorado Denver. (2011, November 30). Medical marijuana laws reduce traffic deaths, preliminary research suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/11/111129123257.htm
University of Colorado Denver. "Medical marijuana laws reduce traffic deaths, preliminary research suggests." ScienceDaily. www.sciencedaily.com/releases/2011/11/111129123257.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins